NASDAQ: INMD
Inmode Ltd Stock

$18.25+0.29 (+1.61%)
Updated Feb 6, 2025
INMD Price
$18.25
Fair Value Price
$28.86
Market Cap
$1.27B
52 Week Low
$14.87
52 Week High
$26.80
P/E
7.97x
P/B
1.8x
P/S
3.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$394.82M
Earnings
$181.28M
Gross Margin
80.3%
Operating Margin
36.34%
Profit Margin
45.9%
Debt to Equity
0.12
Operating Cash Flow
$133M
Beta
1.57
Next Earnings
Feb 11, 2025
Ex-Dividend
N/A
Next Dividend
N/A

INMD Overview

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine INMD's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

A
Value
C
Growth
C
Momentum
F
Sentiment
C
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
INMD
Ranked
#51 of 128

Top Ranked Stocks in Industry

View Top Medical Device Stocks

Be the first to know about important INMD news, forecast changes, insider trades & much more!

INMD News

Overview

Due Diligence Score

–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how INMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

INMD ($18.25) is undervalued by 36.77% relative to our estimate of its Fair Value price of $28.86 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
INMD ($18.25) is significantly undervalued by 36.77% relative to our estimate of its Fair Value price of $28.86 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
INMD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more INMD due diligence checks available for Premium users.

Valuation

INMD fair value

Fair Value of INMD stock based on Discounted Cash Flow (DCF)

Price
$18.25
Fair Value
$28.86
Undervalued by
36.77%
INMD ($18.25) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
INMD ($18.25) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
INMD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

INMD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
7.97x
Industry
41.05x
Market
31.69x
INMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
INMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

INMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.8x
Industry
4.35x
INMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

INMD's financial health

Profit margin

Revenue
$97.9M
Net Income
$82.8M
Profit Margin
84.6%
INMD's Earnings (EBIT) of $143.47M... subscribe to Premium to read more.
Interest Coverage Financials
INMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$785.7M
Liabilities
$81.9M
Debt to equity
0.12
INMD's short-term assets ($714.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INMD's short-term assets ($714.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
INMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$32.4M
Investing
$77.8M
Financing
-$118.4M
INMD's operating cash flow ($132.66M)... subscribe to Premium to read more.
Debt Coverage Financials

INMD vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
INMDC$1.27B+1.61%7.97x1.80x
AHCOB$1.30B-5.01%-5.89x0.86x
AORTB$1.31B-1.36%-1,563.50x4.30x
RXSTC$1.35B-2.01%-40.94x4.88x
FNA–$1.09B-0.08%-14.77x7.81x

Inmode Stock FAQ

What is Inmode's quote symbol?

(NASDAQ: INMD) Inmode trades on the NASDAQ under the ticker symbol INMD. Inmode stock quotes can also be displayed as NASDAQ: INMD.

If you're new to stock investing, here's how to buy Inmode stock.

What is the 52 week high and low for Inmode (NASDAQ: INMD)?

(NASDAQ: INMD) Inmode's 52-week high was $26.80, and its 52-week low was $14.87. It is currently -31.9% from its 52-week high and 22.73% from its 52-week low.

How much is Inmode stock worth today?

(NASDAQ: INMD) Inmode currently has 69,558,670 outstanding shares. With Inmode stock trading at $18.25 per share, the total value of Inmode stock (market capitalization) is $1.27B.

Inmode stock was originally listed at a price of $6.79 in Aug 8, 2019. If you had invested in Inmode stock at $6.79, your return over the last 5 years would have been 168.98%, for an annualized return of 21.88% (not including any dividends or dividend reinvestments).

How much is Inmode's stock price per share?

(NASDAQ: INMD) Inmode stock price per share is $18.25 today (as of Feb 6, 2025).

What is Inmode's Market Cap?

(NASDAQ: INMD) Inmode's market cap is $1.27B, as of Feb 7, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Inmode's market cap is calculated by multiplying INMD's current stock price of $18.25 by INMD's total outstanding shares of 69,558,670.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.